Laetitia Le Texier
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Allogeneic 'off-the-shelf' SARS-CoV-2-specific adoptive T-cell therapy for refractory viral infection and end organ disease.
Journal: Clinical & translational immunology
Published: January 31, 2025
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Journal: Nature communications
Published: May 31, 2024
Breakthrough SARS-COV-2 infection induces broad anti-viral T cell immunity.
Journal: iScience
Published: August 07, 2023
Autophagy prevents graft failure during murine graft-versus-host disease.
Journal: Blood advances
Published: July 05, 2023
Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
Journal: Microbiology spectrum
Published: February 24, 2022
Bone Marrow Regulatory T Cells Are a Unique Population, Supported by Niche-Specific Cytokines and Plasmacytoid Dendritic Cells, and Required for Chronic Graft-Versus-Host Disease Control.
Journal: Frontiers in cell and developmental biology
Published: July 07, 2021
Rapid whole-blood assay to detect SARS-CoV-2-specific memory T-cell immunity following a single dose of AstraZeneca ChAdOx1-S COVID-19 vaccine.
Journal: Clinical & translational immunology
Published: July 06, 2021
'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.
Journal: Journal for immunotherapy of cancer
Published: January 10, 2021
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma.
Journal: NPJ precision oncology
Published: August 16, 2020
Last Updated: 09/26/2026